Seelaus Asset Management LLC Bristol Myers Squibb CO Transaction History

Seelaus Asset Management LLC

$92.7 Million
Q2 2024

A detailed history of Seelaus Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Seelaus Asset Management LLC holds 11,633 shares of BMY stock, worth $618,759. This represents 0.52% of its overall portfolio holdings.

Number of Shares

11,633

Previous 15,612 25.49%

Holding current value

$618,759

Previous $846,000 42.91%

% of portfolio

0.52%

Previous 0.9%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $160,154 - $210,847	-3,979 Reduced 25.49%	11,633 $483,000
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $76,720 - $86,985	-1,599 Reduced 9.29%	15,612 $846,000
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $79,992 - $95,452	-1,650 Reduced 8.75%	17,211 $883,000
Q3 2023 Nov 16, 2023	SELL	$57.89 - $64.73 $61,884 - $69,196	-1,069 Reduced 5.36%	18,861 $1.09 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $546,950 - $607,302	-8,585 Reduced 30.11%	19,930 $1.28 Million
Q1 2023 Apr 19, 2023	SELL	$65.71 - $74.53 $208,629 - $236,632	-3,175 Reduced 10.02%	28,515 $2 Million
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $23,625 - $27,976	-345 Reduced 1.08%	31,690 $2.28 Million
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $26 - $15,368	-200 Reduced 0.62%	32,035 $2.28 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $39,868 - $43,909	-549 Reduced 1.67%	32,235 $2.48 Million
Q1 2022 Apr 13, 2022	SELL	$61.48 - $73.72 $63,324 - $75,931	-1,030 Reduced 3.05%	32,784 $2.39 Million
Q4 2021 Jan 10, 2022	SELL	$53.63 - $62.52 $428,342 - $499,347	-7,987 Reduced 19.11%	33,814 $2.11 Million
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $22,780 - $26,684	-385 Reduced 0.91%	41,801 $2.47 Million
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $465,996 - $507,470	-7,527 Reduced 15.14%	42,186 $2.82 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $63,909 - $71,878	1,077 Added 2.21%	49,713 $3.14 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $67,671 - $76,683	1,172 Added 2.47%	48,636 $3.02 Million
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $70,466 - $78,086	-1,227 Reduced 2.52%	47,464 $2.86 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $71,375 - $83,445	1,302 Added 2.75%	48,691 $2.86 Million
Q1 2020 May 04, 2020	BUY	$46.4 - $67.43 $68,718 - $99,863	1,481 Added 3.23%	47,389 $2.64 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $1.79 Million - $2.34 Million	36,458 Added 385.8%	45,908 $2.95 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $17,108 - $20,284	-400 Reduced 4.06%	9,450 $479,000
Q2 2019 Jul 31, 2019	BUY	$44.62 - $49.34 $8,924 - $9,868	200 Added 2.07%	9,850 $447,000
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $6,768 - $8,070	-150 Reduced 1.53%	9,650 $460,000
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $7,314 - $9,484	150 Added 1.55%	9,800 $509,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $38,948 - $44,837	650 Added 7.22%	9,650 $610,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $539,460 - $588,150	9,000	9,000 $552,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seelaus Asset Management LLC with notifications on news.

Account

Seelaus Asset Management LLC Bristol Myers Squibb CO Transaction History